Osteosarcoma (OSA) is the most common type of cancer that originates in the bone and usually occurs in young children. OSA patients were treated with neoadjuvant chemotherapy and surgery, and the results were disappointing. Marine antimicrobial peptides (AMPs) have been the focus of antibiotic research because they are resistant to pathogen infection. Piscidin-1 is an AMP from the hybrid striped bass (Morone saxatilis × M. chrysops) and has approximately 22 amino acids. Research has shown that piscidin-1 can inhibit bacterial infections and has antinociception and anti-cancer properties; however, the regulatory effects of piscidin-1 on mitochondrial dysfunction in cancer cells are still unknown. We aimed to identify the effects of piscidin-1 on mitochondrial reactive oxygen species (mtROS) and apoptosis in OSA cells. Our analyses indicated that piscidin-1 has more cytotoxic effects against OSA cells than against lung and ovarian cancer cells; however, it has no effect on non-cancer cells. Piscidin-1 induces apoptosis in OSA cells, regulates mtROS, reduces mitochondrial antioxidant manganese superoxide dismutase and mitochondrial transmembrane potential, and decreases adenosine 5′-triphosphate production, thus leading to mitochondrial dysfunction and apoptosis. The mitochondrial antioxidant, mitoTempo, reduces the apoptosis induced by piscidin-1. Results suggest that piscidin-1 has potential for use in OSA treatment.
Results

Influence of Piscidin-1 on the cell viability of various cancer and noncancer cells and morphological changes in OSA cells.
We first determined the cytotoxicity of treatment with piscidin-1 for 24 h on various cancer and noncancer cell lines by using 3-(4,5-dimethylthiazol-2-yl)-2,5 -diphenyltetrazolium bromide (MTT) staining, and the results showed that the effects of the treatment were dose-dependent. At piscidin-1 concentrations of 1, 5, and 10 μM, the viability of the human OSA cells (MG63 cell line) decreased to 66.99 ± 6.69%, 50.86 ± 14.44%, and 40.15 ± 8.32% of that in the control, respectively (100 ± 11.36%, 0 μM piscidin-1) (Fig. 1A) . The similar concentration dose-dependent effect could be observed in piscidin-1-treated OSA 143B cells for 24 h (Fig. S2A ). Piscidin-1 increased cytotoxicity in MG63 and 143B cells in a dose-dependent and time-dependent manner after 48 and 72 h treatment ( Fig. S1 ). At piscidin-1 concentrations of 1, 5, and 10 μM, the viability of human lung adenocarcinoma cells (A549 cell line) was clearly reduced to 81.84 ± 11.63%, 72.39 ± 16.40%, and 53.79 ± 10.19% of that in the control, respectively (0 μM, 100 ± 6.52%) ( Fig. 1B) , whereas the viability of human ovarian cancer cells (SKOV-3 cell line) was also substantially reduced to 87.12 ± 11.46%, 79.61 ± 9.26%, and 66.34 ± 6.79% of that in the control, respectively (100 ± 2.70%, 0 μM piscidin-1) (Fig. 1C) ; however, piscidin-1 did not exhibit obvious cytotoxic effects on nontumor cells, such as human primary gingival fibroblast cells (HGF-1 cell line) ( Fig. 1D ) and human oral mucosal fibroblast cells (OMF cell line) (Fig. 1E ). The scanning electron microscope micrographs of MG63 cells were observed after treatment with of 0.1 and 10 μM piscidin-1 for 24 h. Apoptosis is the process through which a cell undergoes programmed death. At a magnification of 200X, the structure of the MG63 cells become spherical as their cytoskeletons are digested in 10 μM piscidin-1; at a magnification of 400X, cell shrinkage representing apoptosis is observed (Fig. 1F) . These results suggest that although piscidin-1 can inhibit cancer cell viability, it has no influence on noncaner cells.
Influence of Piscidin-1 on OSA cells apoptosis.
To further elucidate the link between the OSA cell apoptosis induced by piscidin-1, we conducted an in vitro proof-of-principle study. First, we used annexin V-FITC (green) and propidium iodide (PI)-red staining with flow cytometry dot-plot diagrams to analyze the apoptosis induced by piscidin-1. Figure 2A shows the typical shift between apoptotic cells (annexin V+/PI−) and dead cells (annexin V+/PI+) from the left quadrant toward the right quadrant in MG63 cells treated with piscidin-1 for 24 h. At 5 and 10 μM piscidin-1, the rates of apoptotic and dead MG63 cells (14.48 ± 4.38% and 45.59 ± 3.61%, respectively) obviously increased compared with those in the control (4.61 ± 0.16%, 0 μM piscidin-1) ( Fig. 2B) , whereas a similar phenomenon can also be observed in piscidin-1-treated 143 B cells (Fig. S2B,C) . Furthermore, a terminal deoxy-nucleotidyl transferase dUTP nick end labeling (TUNEL) assay was conducted in vitro to evaluate the apoptotic effect of piscidin-1 and observe the apoptotic cells that exhibited extensive DNA fragmentation during apoptosis 29 . TUNEL staining (green) was exhibited using immunofluorescence and showed nuclear condensation and apoptotic bodies in the MG63 cells after treatment with 10 μM piscidin-1, and all nuclei (blue) were stained with 4′,6-diamidino-2-phenylindole (DAPI) (Fig. 2C ). Our data show that there was an increasing trend in TUNEL-positive cells in the groups treated with 5 (19.48 ± 4.38%) and 10 μM (40.59 ± 3.60%) piscidin-1 compared with that in the control (5.11 ± 1.39%, 0 μM piscidin-1) (Fig. 2D ). The intrinsic apoptosis pathway is initiated by the disruption of the inner mitochondrial membrane under excessive oxidative stress, thus resulting in the release of cytochrome c (cyt c) protein 30 , whereas the downstream caspase-3 has been identified as an important executioner of the apoptosis process 31 . After normalization of the protein with β-actin, analysis revealed that the exposure of MG63 cells to different concentrations of piscidin-1 for 24 h increased the expression levels of cytosolic cyt c, cleaved caspase-9, and cleaved caspase-3 ( Fig. 2E ). After protein normalization with cyt c oxidase complex IV (COX IV), the mitochondrial cyt c was not affected. MG63 cells that were treated with different concentrations of piscidin-1 (i.e., 0, 1, 5, and 10 μM) for 24 h exhibited a rapid accumulate in cytoplasmic cyt c protein levels of 1.00 ± 0.33, 15.89 ± 1.93, 18.06 ± 1.50, and 18.20 ± 5.00 in a dose-dependent manner, but mitochondrial cyt c was not affected (Fig. 2F ). The piscidin-1 treatment of the MG63 cells with 1, 5, and 10 μM obviously increased the protein levels of cleaved caspase-9 in a dose-dependent manner to 3.18 ± 0.50, 4.76 ± 0.73, and 5.67 ± 0.86, respectively, compared with that of the control at 1.00 ± 0.17 (0 μM piscidin-1). The piscidin-1 treatment of the MG63 cells with 1, 5, and 10 μM also led to a dose-dependent increase in the levels of which were treated with 0, 0.1, 1, 5, or 10 μM piscidin-1 for 24 h and assayed using MTT staining to measure cell viability. Piscidin-1 did not obviously influence the cell viability of two noncancer cell lines. (D) Human primary gingival fibroblast cells (HGF-1) cells and (E) oral mucosal fibroblast (OMF) cells were treated with the 0, 0.1, 1, 5, or 10 μM piscidin-1 for 24 h and assayed using MTT to measure the changes in cell viability. Cell viability is expressed as a percentage of the untreated control cells (0 μM). The results are expressed as the mean ± SEM of three independent experiments. Significance was determined using Student's t-test. *p < 0.05; **p < 0.01. (F) MG63 cells were treated with 0, 0.1, and 10 μM piscidin-1 for 24 h, and images were taken with a scanning electron microscope. The photograph represented 200X (upper) and 400X (lower) magnification. cleaved caspase-3 at 11.6121 ± 6.17, 16.52 ± 2.92, and 28.02 ± 4.62, respectively, compared with that of the control at 1.00 ± 0.43 (0 μM piscidin-1) ( Fig. 2G ). These observations indicated that piscidin-1-induced apoptosis in OSA cells is through the release of cyt c from the mitochondria and the subsequent activation of caspase-9 and caspase-3. β-actin and COX IV were used as the cytosol and mitochondria internal controls, respectively. The groupings were cropped from different gels subjected to identical conditions. Full blots are shown in the Supplementary Information, Fig. S4 . Cytosol cytochrome c, mitochondrial cytochrome c (F), and protein levels of cleaved caspase-9 and cleaved caspase-3 (G) were quantified and normalized to that of β-actin and COX IV and were expressed as fold changes. Significance was determined using Student's t-test. *p < 0.05; **p < 0.01.
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www.nature.com/scientificreports www.nature.com/scientificreports/ Effect of Piscidin-1 on mtROS, mitochondrial transmembrane potential, and mitochondrial antioxidant manganese superoxide dismutase. ROS is generated mainly by the mitochondria; however, excess ROS production can be the cause of oxidative damage and cell death, followed by loss of mitchondrial transmembrane potential (MTP) 32 . MtROS was detected by flow cytometry using Mitochondrial Superoxide Indicator (MitoSOX Red) stain. MtROS accumulation was enhanced after treatment with 10 μM piscidin-1 for 24 h, and flow cytometry showed a considerable shift to the right in MG63 cells (Fig. 3A) . The quantitative results indicated that at concentrations of 0.1, 1, 5, and 10 μM piscidin, mtROS in MG 63 cells clearly increased, in a dose-dependent manner, to 15.75 ± 0.42%, 20.66 ± 0.64%, 27.63 ± 0.77%, and 89.01 ± 2.04%, respectively, compared with that in the control (6.15 ± 0.82%, 0 μM piscidin-1) ( Fig. 3B) . A similar phenomenon could also be observed in piscidin-1-treated 143 B cells ( Fig. S2D,E) . A rhodamine 123 probe was used to detect changes in (E) The cell lysates were used for Western blot analysis with an anti-SOD2 antibody, and β-actin was used as the internal control. The groupings were cropped from different gels subjected to identical conditions. Full blots are shown in the Supplementary Information, Fig. S5 . (F) SOD2 protein levels were quantified after being normalized with β-actin. The results are expressed as the mean ± SEM of three independent experiments. Significance was determined using Student's t-test; *p < 0.05; **p < 0.01.
MTP after piscidin-1 treatment. In the MG63 cells treated with 10 μM piscidin-1 for 24 h, MTP was disrupted, and the flow cytometry histogram showed a considerable shift to the left (Fig. 3C ). The quantitative results indicated that at concentrations of 1, 5, and 10 μM piscidin-1, the MTP in MG 63 cells apparently decreased to 64.19 ± 2.90%, 59.87 ± 1.44%, and 35.66 ± 1.28%, respectively, compared with that in the control (75.85 ± 0.99%, 0 μM piscidin-1) (Fig. 3D ). The same phenomenon was also seen in piscidin-1-treated 143B cells ( Fig. S2F ,G). Mitochondrial antioxidant manganese superoxide dismutase (SOD2 or MnSOD) is located in the mitochondrial matrix and protects it against excessive oxidative stress 33 . Thereafter, we examined whether antioxidants were involved in the ROS overproduction induced by piscidin-1 in MG63 cells. The results revealed that piscidin-1 treatment downregulated SOD2 protein expression ( Fig. 3E ) and decreased SOD2 protein levels in the MG63 cells from 1.00 ± 0.13 in the control to 0.55 ± 0.06, 0.40 ± 0.04, and 0.41 ± 0.05 after treatment with 1, 5, and 10 μM piscidin-1, respectively (Fig. 3F ). These results suggested that mtROS overproduction, antioxidant (SOD2) reduction, and MTP disruption contribute to the cell apoptosis induced by piscidin-1.
Effect of Piscidin-1 on oxygen consumption rate in OSA cells.
A previous study has reported that oxidative stress causes changes in mitochondrial oxygen consumption in many different types of cancer cells 34 . The mitochondrial oxygen consumption rate (OCR), which is a measure of mitochondrial respiration and mitochondrial activity, was measured in the MG63 and 143B cells treated with piscidin-1 for 24 h. Several mitochondrial respiratory phase profiles were calculated on the basis of the OCR after sequentially and continuously adding oligomycin, 2-[2-[4-(trifluoromethoxy) phenyl] hydrazinylidene]-propanedinitrile (FCCP), and antimycin A/rotenone respiratory inhibitors to inhibit the ETC (Fig. 4A ). Treatment with various concentrations of piscidin-1 in MG63 cells decreased OCR (y-axis, pMole/min/mg protein) in a dose-dependent manner (Fig. 4B ). As the concentration of piscidin-1 increased, the basal respiration OCR values apparently decreased to 94.53 ± 10.15, 94.02 ± 20.47, and 40.87 ± 10.80 pMole/min/mg protein at concentrations of 1, 5, and 10 μM piscidin-1, respectively, compared with that in the control (121.48 ± 10.57 pMole/min/mg protein, 0 μM piscidin-1) ( Fig. 4C ). Statistically differences were observed in adenosine 5′-triphosphate (ATP) production, thus indicating that the OCR values of coupled respiration (ATP production) were attenuated to 65.31 ± 4.82, 63.66 ± 17.78, and 18.59 ± 10.45 pMole/min/mg protein in concentrations of 1, 5, and 10 μM piscidin-1, respectively, compared with that in the control (102.13 ± 17.12 pMole/min/mg protein, 0 μM piscidin-1) ( Fig. 4D ). No obvoius changes were observed in the trend for proton leak (uncoupled respiration) after the same treatment with various concentrations of piscidin-1 for 24 h (Fig. 4E ). Adding 1, 5, and 10 μM piscidin-1 obviously reduced the maximum respiration to 190.24 ± 88.63, 115.40 ± 40.13, and 82.86 ± 5.64 pMole/min/mg protein, respectively, compared with that in the control (310.28 ± 35.46 pMole/min/mg protein, 0 μM piscidin-1) (Fig. 4F ). The spare respiration capacity also exhibited a dose-dependent reduction from 211.03 ± 38.21 in the control at a concentration of 0 μM piscidin-1 to 121.24 ± 61.06, 42.17 ± 34.29, and 41.99 ± 11.90 pMole/min/mg protein at concentrations of 1, 5, and 10 μM, respectively (Fig. 4G ). The non-mitochondrial respiration graph showed that as the concentration of piscidin-1 increased, the non-mitochondrial respiration value or extracelluar acidification rates decreased to 90.88 ± 20.05 and 49.47 ± 28.56 pMole/min/mg protein at 5 and 10 μM piscidin-1, respectively, compared with that in the control (135.25 ± 18.27 pMole/min/mg protein, 0 μM piscidin-1) ( Fig. 4H ). Piscidin-1 similarly inhibited mitochondrial respiration in 143B cells (Fig. S3 ). These results suggest that piscidin-1 effectively decreases basal respiration, ATP production, maximum respiration, spare respiratory capacity, and non-mitochondrial respiration in both OSA cells; the proton leak remains unaffected.
Effects of antimicrobial peptide Piscidin-1 on ETC Complex I-V Proteins and ATP production in MG63 cells. The mitochondrial inner membrane contains important ETC organs that act as sites
for OXPHOS and ATP synthesis, which is a major mitochondrial function 35 . Western blot analysis was conducted to examine the changes in the protein expressions of the ETC family after piscidin-1 treatment, including complex I (NDUFB8), complex II (SDHB), complex III (UQCRC2), complex IV (COX II), and complex V (ATP5A) proteins. The results showed that the exposure of MG63 cells to different concentrations of piscidin-1 for 24 h substantially reduced the expression levels of mitochondrial ETC complexes I-V proteins (Fig. 5A ). Different concentrations of piscidin-1 treatment on MG63 cells for 24 h led to drastically reduced complex I (NADH dehydrogenase) protein levels and was normalized to β-actin protein from 1.00 ± 0.10 (control, 0 μM piscidin-1) to 0.58 ± 0.12, 0.40 ± 0.09, and 0.44 ± 0.04 at 1, 5, and 10 μM piscidin-1 in a dose-dependent manner, respectively (Fig. 5B) . The piscidin-1 treatment of MG63 cells for 24 h drastically reduced transmembrane respiratory complex II protein (succinate dehydrogenase) levels from 1.00 ± 0.05 (control, 0 μM piscidin-1) to 0.53 ± 0.03, 0.05 ± 0.02, and 0.03 ± 0.02 at 1, 5, and 10 μM piscidin-1, respectively (Fig. 5C) . A similar phenomenon was observed in the mitochondrial complex III (ubiquinol-cytochrome c reductase complex) protein, which was reduced in a dose-dependent manner from 1.00 ± 0.09 (control, 0 μM piscidin-1) to 0.60 ± 0.03, 0.45 ± 0.10, and 0.29 ± 0.10 in cells treated for 24 h with 1, 5, and 10 μM piscidin-1 (Fig. 5D ). The expression levels of complex IV (cyt c oxidase) protein in the MG63 cells were obviously downregulated after treatment for 24 h with 1 (0.65 ± 0.08), 5 (0.59 ± 0.02), and 10 μM (0.55 ± 0.12) piscidin-1 compared with that in the control at 0 μM piscidin-1 (1.00 ± 0.02) (Fig. 5E ). The expression levels of mitochondrial membrane ATP synthase (complex V) protein in the MG63 cells were reduced after treatment for 24 h with 5 (0.3 ± 0.14) and 10 μM (0.11 ± 0.07) piscidin-1 compared with that in the control at 0 μM piscidin-1 (1.00 ± 0.10) (Fig. 5F ). The ATP concentrations markedly decreased in the MG63 cells after treatment for 24 h with 5 (22.86 ± 2.58 μM/2 × 10 5 cells) and 10 μM (15.22 ± 2.60 μM/2 × 10 5 cells) piscidin-1 compared with that in the control at 0 μM piscidin-1 (47.38 ± 6.40 μM/2 × 10 5 cells) (Fig. 5G) . These results suggest that piscidin-1 can effectively decrease the expression levels of complexes I, II, III, IV, and V protein and inhibit ATP production in the MG63 cells.
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www.nature.com/scientificreports www.nature.com/scientificreports/ Effects of Piscidin-1 on mitochondrial dynamic proteins. The mitochondrial fusion proteins were MFN1, MFN2, and OPA1; the mitochondrial fission proteins were DRP1 and FIS1. Our results showed that piscidin-1 treatment for 24 h obviously reduced the expression levels of MFN1, MFN2, and OPA1 fusion proteins but enhanced those of DRP1 and FIS1 fission proteins in MG63 cells (Fig. 6A ). Piscidin-1 treatment increased DRP1 protein levels in a dose-dependent manner from 1.00 ± 0.12 in the control (0 μM) to 1.37 ± 0.04, 1.71 ± 0.04, and 1.82 ± 0.04 at 1, 5, and 10 μM piscidin-1, respectively (Fig. 6B ). Piscidin-1 treatment also increased the FIS1 protein levels from 1.00 ± 0.05 in the control (0 μM) to 1.79 ± 0.22 and 1.71 ± 0.21 at 5 and 10 μM piscidin-1, respectively (Fig. 6C) . Furthermore, our results demonstrated that piscidin-1 reduced the MFN1 protein levels from 1.00 ± 0.05 in the control (0 μM) to 0.41 ± 0.05 at 10 μM piscidin-1 (Fig. 6D ). MFN2 protein was also reduced in the cell to 0.66 ± 0.05, 0.56 ± 0.07, and 0.54 ± 0.05 after treatment with 1, 5, and 10 μM piscidin-1 for 24 h, respectively, compared with that in the control (1.00 ± 0.16, 0 μM) (Fig. 6E ). Western The OCR was measured before and after adding pharmacological agents to living cells. Three measurements were taken and averaged to provide reliable data at the start, followed by sequential and continuous injections of oligomycin, FCCP, and antimycin A/rotenone. These analyses measured the basic parameters of basal respiration, ATP production, proton leak, maximum respiration, spare respiratory capacity, and nonmitochondrial respiration. (B) OCR value and time-course curve plot. The parameters quantified and analyzed in MG63 cells treated with 0, 0.1, 1, 5, and 10 μM piscidin-1 were the (C) basal respiration OCR, (D) ATP production (couple respiration), (E) proton leak, (F) maximal respiration, (G) spare respiratory capacity, and (H) non-mitochondrial respiration. OCR values were quantified by normalizing the cell protein concentration. The results are expressed as the mean ± SEM of three independent experiments. Significance was determined by Student's t-test; *p < 0.05; **p < 0.01. blot analysis also showed a considerable reduction in OPA1 protein expressions to 0.31 ± 0.01, 0.18 ± 0.01, and 0.19 ± 0.01 in the cells treated for 24 h with 1, 5, and 10 μM piscidin-1 compared with that in the control (1.00 ± 0.11, 0 μM) (Fig. 6F) . These results suggested that piscidin-1 can effectively increase the expression level of mitochondrial fission proteins and decrease the expression level of fusion proteins in MG63 cells.
Pretreatment with mtROS scavengers rescue the mtROS increase, MTP dissipation, and apoptosis induced by Piscidin-1. mitoTempo is a mitochondria-targeting antioxidant and an mtROS scavenger,
i.e., it protects the mitochondria from oxidative damage 36 . To determine the effect of mitoTempo on mtROS overproduction, MTP dissipation, and apoptosis induced by piscidin-1, MG63 cells were pretreated with or without 5 μM mitoTempo for 2 h. Thereafter, 10 μM piscidin-1 was added and allowed to react for 24 h. The fluorescence intensity of MitoSOX Red showed a 7.38 ± 0.59-fold change in the mitoTempo and piscidin-1 cotreatment group and a 16.09 ± 1.24-fold change in the piscidin-1-only treatment group compared with that in the dimethyl sulfoxide (DMSO) control group, thus indicating that cotreatment with mitoTempo substantially reduced mtROS production in MG63 cells treated with piscidin-1 (Fig. 7A) . The piscidin-1 (10 μM) treatment of MG63 cells for 24 h induced MTP dissipation, but the pretreatment of the cells with mitoTempo effectively rescued this dissipation from an MTP of 44.69 ± 3.87% to an MTP of 95.72 ± 4.67% (Fig. 7B ). To evaluate whether mitoTempo attenuates the cell apoptosis induced by piscidin-1, MG63 cells were treated with piscidin-1, mitoTempo, or both for 24 h. The proportion of dead cells (upper right) and apoptotic cells (lower right) were calculated using the gated www.nature.com/scientificreports www.nature.com/scientificreports/ quadrant dot-plot profile (Fig. 7C ). The fold change was 0.99 ± 0.09 in the group treated with both mitoTempo and piscidin-1 and was 3.23 ± 0.22 in the group treated with only piscidin-1 compared with that in the DMSO vehicle control, thus suggesting that there was a considerable reduction in cell apoptosis from cotreatment with mitoTempo ( Fig. 7D) . Our data indicate that piscidin-1 treatment increased mtROS production, disrupted MTP integrity, and promoted cell apoptosis, whereas pretreatment with mitoTempo sharply suppressed mtROS and cell apoptosis and reduced MTP dissipation.
Discussion
Piscidin-1 peptide, which was generously donated by the laboratory of Professor Jyh-Yih Chen at Academia Sinica, Jiaushi, Ilan, Taiwan, is one of the AMP series and natural marine compounds isolated from the mast cells of the hybrid striped bass (Morone saxatilis × M. chrysops). Piscidin-1 is composed of approximately 22 amino acid peptides with amphiphilic α-helical conformation structure and has a small molecular weight of ~2.5 kDa. Previous studies have shown that piscidin-1 can inhibit bacterial proliferation 27 , induce Hela and fibrosarcoma cell apoptosis 28 , and relieve pain 37 . Our results demonstrate that piscidin-1 obviously reduces the cell viability of MG63 cells (IC 50 = 6.72 ± 2.31 µM) and 143 cells (IC 50 = 7.15 ± 1.55 µM) compared with that in A549 cells (IC 50 = 9.93 ± 1.25 µM) and SKOV3 cells (IC 50 = 13.56 ± 1.84 µM); however, piscidin-1 has no effect on HGF-1 or OMF. The process of apoptosis is generally identified by distinct morphological characteristics (including DNA strand breaks, externalization of phosphatidylserine residues on the cell surface, cell shrinkage, chromosome www.nature.com/scientificreports www.nature.com/scientificreports/ condensation, and cell apoptotic body formation) and is an energy-dependent mechanism 36 . Most natural marine compounds with anticancer properties have complex action mechanisms, among which the regulations of the apoptosis induction and mitochondrial dysfunction signaling networks play key roles 38 . First, we observed the morphological changes in OSA cells treated with piscidin-1 by using scanning electron microscopy, and the results showed that the structure of the cell cytoskeleton became spherical at low concentrations of the peptide. High concentrations of the peptide induced cell shrinkage, which represents cell apoptosis. The additional examinations using flow cytometric annexin V/PI staining, TUNEL fluorescence assay, and Western blot analysis using antibodies against apoptosis factors (cyt c, cleaved caspase-9, and cleaved caspase-3) confirmed that piscidin-1 induces apoptosis. The current study demonstrated that piscidin-1 treatment inhibits OSA cell growth at low concentrations, with an IC 50 of ~6-7 µM. Lin et al. reported that piscidin-1 induces cell death in HeLa and HT1080 cells with an IC 50 of ~7-8 µM 28 , similar to that in our results. Furthermore, our experiments show that the antitumor activity of piscidin-1 in OSA cells was initiated by inducing apoptosis, and this finding is consistent with the results of a previous report 28 .
MtROS are harmful substances and are the undesirable byproducts of oxidative phosphorylation, which indefinitely damages cells; however, superoxide anion (O 2 − ) and hydrogen peroxide (H 2 O 2 ) are major ROS and important signaling molecules and are directly involved in the regulation of mitochondrial and cellular functions 39 . Considering that SOD2 enzymes can extensively catalyze undue ROS in the mitochondria, they are involved in ROS production and in changes in the respiratory chain complex process 40 . Apoptosis induction uses two main pathways, namely, extrinsic (death receptor) and intrinsic (mitochondria mediated) 41, 42 . The intrinsic pathway regulates the permeability of the mitochondrial outer membrane and creates pores in this membrane that cause apoptosis-inducing factors, such as cyt c, to be constantly released into the cytoplasm. Cyt c and caspase-9 combine to form an apoptosome and subsequently activate caspase-3, thus causing apoptosis and death. It is www.nature.com/scientificreports www.nature.com/scientificreports/ worth noting that the accumulation of mtROS precedes MTP (ΔΨm) damage, nuclear condensation, and apoptotic body formation 43 . This study demonstrated that the effective cytotoxicity of and the apoptosis induced by piscidin-1 on OSA cells is achieved by the induction of mtROS and the disruption of MTP; however, we also observed that piscidin-1 increases mtROS levels at very low concentrations (0.1 µM) before the observed MTP dissipation (1 µM).
The mitochondria plays many important roles in eukaryotic cells, the most important of which is the production of ATP during the OXPHOS process 44 . There are two ways that cells produce ATP: OXPHOS (in the mitochondria) and non-mitochondrial (in the cytoplasm) processes. Our study showed that piscidin-1 reduces non-mitochondrial and OXPHOS respiration, including the basal OCR, ATP production, maximum respiration OCR, spare respiration capacity, and non-mitochondrial respiration but has no effect on proton leak respiration in OSA cells. The inner membrane of the mitochondria has many folds (cristae), which accommodate many copies of the respiratory chain component or OXPHOS complexes I-V. Complexes I-V is multi-subunit enzymes that synergistically produce an electrochemical proton gradient on the inner mitochondrial membrane. Finally, together with complex V (ATP synthase), they form the machinery for producing ATP, which is the source of cell metabolism and cell biosynthesis and is also known as the energy currency of cells 45 . The expression levels of complex I-V proteins were gradually reduced with increased concentrations of piscidin-1. The cell mitochondrial stress test using a Seahorse XF24 Analyzer and the expressions of complex I-V proteins indicated that the mitochondria exhibited a two-stage change as the piscidin-1 concentration increased. First, it was stimulated and damaged, efficiency was slightly reduced, and it maintained stable operations. Second, if the damage was too extensive, it would not be able to work appropriately, and the entire cell would be on the verge of collapse. This indicated that piscidin-1 has obvious apoptosis effects on OSA cells by inhibiting mitochondrial OXPHOS and the expression of complexes I-V, thus decreasing ATP production and finally causing mitochondrial dysfunction.
Mitochondria are dynamic organelles that exhibit fusion (combining pieces) and fission (splitting into smaller pieces) via the active recruitment of specific proteins to the indicated locations within the organelle. Mitochondrial fusion requires three large GTPases, the outer membrane proteins MFN1 and MFN2 and the inner membrane protein OPA1. The activation of GTPase DRP1 and the outer membrane protein FIS1 is necessary for mitochondrial fission. Mitochondrial fusion and fission have several important functions. They control the morphology of the mitochondria and allow for the exchange of content between the mitochondria, thus controlling mitochondrial distribution and promoting the release of membrane gap proteins during apoptosis 46 . Several structural changes in the mitochondria are important for rapid and efficient apoptosis they must have a fragmented expression with the permeable outer membrane, and the cristae must be disconnected; therefore, mitochondrial fission has significant implications in oxidative stress response and apoptosis 47 . Our results are consistent with the aforementioned observation, i.e., the induction of apoptosis by piscidin-1 is responsible for a decrease in the mitochondrial fusion proteins and an increase in the mitochondrial fission proteins in OSA cells.
MitoTempo is a mitochondria-targeted antioxidant with superoxide scavenging properties, i.e., it helps protect against oxidative damage to the mitochondria 48 . Many researches have proved that mitoTempo maintains mitochondrial integrity and reduces necrosis and apoptosis 48, 49 . Our results demonstrated that piscidin-1 induces OSA cell apoptosis by increasing mtROS production and destroying MTP. Pretreatment with mitoTempo significantly decreases the overproduction of mitochondrial superoxide radical, the disruption of MTP, and the apoptosis mediated by perscidin-1 in the OSA cells.
Most of the defense peptides with anticancer activity are cationic and the molecular structures are either α-helical or β-sheet. Compared with normal cells, the cellular membrane of cancer cells contains more anions such as heparin sulfate and phospholipid phosphatidylserine, so that the cell membrane exhibits net negative charge. During the early stage of apoptosis, the mitochondria gradually become negatively charged with the increase of cardiolipin exposure; therefore, piscidin-1 entering OSA cells will attack and destroy the integrity of the mitochondria 50 . Current studies suggest that the selectivity and underlying mechanism of these anti-cancer peptides depends on invasion of mitochondrial and/or plasma membranes of cancer cells by potential differences, leading to cell apoptosis 51 . Piscidin-1 with positive charge possesses an α-helical structure, and the specific anticancer ability we observed may be caused by the aforementioned mechanism 28 .
The results of this study showed that piscidin-1, which is a marine pepide, inhibits MG63 and 143B OSA cell growth by inducing the apoptosis pathway ( Fig. 8 ). Piscidin-1 treatment enhances mtROS production and decreases SOD2 antioxidant expression, followed by disrupting OXPHOS, decreasing the expression of complex I-V proteins, inducing an imbalance in mitochondrial dynamic proteins (including increased fission proteins and decreased fusion proteins), dissipating MTP (Δψm) and ATP production, and causing cancer cell apoptosis. MitoTempo is effective in reducing the apoptosis mediated by piscidin-1. These results indicate that piscidin-1 possesses anticancer effects by increasing mtROS and inducing mitochondrial dysfunction. To the best of our knowledge, this is the first report to demonstrate that piscidin-1 can inhibit human cancer growth by influencing mtROS, OXPHOS, and mitochondrial function. The above characteristics indicate that piscidin-1 has the potential for additional research and development as a new chemotherapeutic drug.
Methods
Cell lines and culture. MG63 (ATCC ® CRL-1427) and 143B (ATCC ® CRL-8303) osteosarcoma cells, lung cancer A549 cells (ATCC ® CCL-185), ovarian cancer SKOV3 cells (ATCC ® HTB-77), and primary gingival fibroblast (HGF-1) cells (ATCC ® PCS-201-018) were purchased from the American Type Culture Collection (Manassas, VA, USA). Human oral mucosal fibroblast (OMF) cells were a kind gift from Professor Michael Hsiao of Academia Sinica Institute, Taiwan. A549 cells were maintained in F12K medium (Gibco BRL, Rockville, MD, USA), HGF-1 and OMF cells were cultured with Dulbecco's Modified Eagle's Medium (DMEM; Gibco), SKOV3 cells were cultured in Roswell Park Memorial Institute 1640 medium (Gibco), and MG63 and 143B cells were cultured with Minimum Essential Medium Eagle Alpha Modification medium (Gibco). Ten-percent Scanning electron microscopy morphological analysis. The scanning electron microscopy sample was prepared on the basis of the methods of Kung et al. 52 . The cell cultures were washed with PBS and subjected to dehydration in a graded alcohol series for 2 min each (10%, 25%, 50%, 75%, and absolute ethanol v/v % ethanol). After dehydration, the samples were mounted on copper plates and sputter-coated with a thin layer of gold. Finally, the scanning electron microscope images were obtained using the JEOL JSM-7000F scanning electron microscope at an accelerating voltage of 5 kV.
Cell viability. The cells were seeded at an initial density of 6 × 10 3 cell/well in 96-well plates and placed on a culture plate into a CO 2 incubator at 37 °C overnight. After piscidin-1 treatment with 0, 0.1, 1, 5, and 10 µM for 24, 48, and 72 h, 20 µL 5 mg/mL MTT solution was added into the cell-attached wells for 4 h. The supernatant was removed and intracellular formazan compounds were solubilized in 100 µL/well DMSO at room temperature for 15 min. The absorbance at a wavelength of 570 nm was measured using an enzyme-linked immunosorbent assay microplate reader (Dynatech Laboratories, Chantilly, VA, USA). The relative cell viability was calculated as the percentage of cells treated with piscidin-1 and those in the untreated control group.
Flow cytometric analyses for apoptosis. Apoptosis was measure by fluorescence levels after staining with annexin V-FITC and PI. The seeded 5 × 10 5 cells were plated in six-well plates and incubated overnight. MG63 and 143B cells were treated with piscidin-1 at 0, 0.1, 1, 5, and 10 μM for 24 h, another group was treated with or without mitoTempo for 2 h, and 10 μM piscidin-1 was added and allowed to react for 24 h. The resuspended cells at 1 × 10 5 cells/100 μL in working binding buffer (HBSS) containing 5 μL purified recombinant annexin V-FITC and 5 μL PI were gently mixed and incubated for 10 min at room temperature to avoid light, and 1 mL HBSS solution was added. Beckman Coulter's CytoFLEX (Southfield, MI, USA) was used to detect the fluorescence intensity of annexin V (green fluorescence)/PI (red fluorescence). At least 20,000 cells/group were analyzed using CytExpert 2.0 software (Beckman Coulter). TUNEL staining and fluorescence image. For the TUNEL assay purchased from Roche, 1 × 10 5 cells/ well were set on glass coverslips for each well in a 12-well plate for at least 24 h and were subsequently treated 
